Multiple Sclerosis Therapeutics Market is estimated to be US$ 30.62 billion by 2030 with a CAGR of 2.50% during the forecast period prophecymarketinsights.com

The report “Global Multiple Sclerosis Therapeutics Market, by Drug Class (Beta Interferon, Corticosteroids, Monoclonal Antibodies, Antineoplastic Agents, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) – Trends, Analysis and Forecast till 2030”